Armata Pharmaceuticals Inc (ARMP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $10.72
• Market Cap: $387.00M
• EPS: $-1.66
• 52-Week High: $12.23
• 52-Week Low: $0.90

Market Sentiment

Armata Pharmaceuticals Inc currently has a Bullish sentiment score of 0.56.

About Armata Pharmaceuticals Inc

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Marina del Rey, California, focused on developing innovative bacteriophage-based therapies to tackle the escalating threat of antibiotic-resistant infections. By harnessing advanced technologies and deep research expertise, Armata aims to deliver precision medicine solutions that address urgent needs in infectious disease management. The company is building a robust pipeline of therapeutic candidates and establishi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Armata Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ARMP pay dividends?

Armata Pharmaceuticals Inc (ARMP) does not currently pay a regular dividend.

What is ARMP's market cap?

Armata Pharmaceuticals Inc (ARMP) has a market capitalization of $387.00M with a current stock price of $10.72.